Optimizing lung transplant immunosuppression: Beyond calcineurin inhibition

Journal of Thoracic and Cardiovascular Surgery

Volumn 125, Issue 4, 2003, Pages 784-786

  Mulligan, Michael S ^a   Wood, Douglas E ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCINEURIN; CALCINEURIN INHIBITOR; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; TACROLIMUS;

BRONCHIOLITIS; DRUG MECHANISM; EDITORIAL; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG TRANSPLANTATION; METHODOLOGY; PRIORITY JOURNAL; PROPHYLAXIS; TREATMENT FAILURE;

EID: 0037393892     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2003.204     Document Type: Editorial

References (5)

1. Solomon MJ, Laxamana A, Devore L, McLeod RS. Randomized controlled trials in surgery. Surgery. 1994;115:707-12.
2. Zuckermann A, Reichenspurner H, Birsan T, Treede H, Deviatko E, Reichart B, et al. Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial. J Thorac Cardiovasc Surg. 2003;125:891-900.
3. Palmer SM, Miralles AP, Lawrence CM, Gaynor JW, Davis RD, Tapson VF. Rabbit antithymocyte globulin decreases acute rejection after lung transplantation: results of a randomized, prospective study. Chest. 1999;116:127-33.
4. Brock MV, Borja MC, Ferber L, Orsens JB, Anzcek RA, Krishnan J, et al. Induction therapy in lung transplantation: a prospective, controlled clinical trial comparing OKT3, anti-thymocyte globulin and daclizumab. J Heart Lung Tranplant. 2001;20:1282-90.
5. Pham SM, Rao AS, Zeevi A, McCurry KR, Keenan RJ, Vega JD, et al. Effects of donor bone marrow infusion in clinical lung transplantation. Ann Thorac Surg. 2000;69:345-50.